Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 9, 2025
RAPPEL : Rogers Sugar Inc. : Appel conférence – Résultats du 2ème trimestre 2025
GlobeNewswire
·
May 9, 2025
MONTRÉAL, 09 mai 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (RSI) tiendra une téléconférence pour discuter des résultats de son deuxième trimestre 2025 mardi le 13 mai 2025 à 8h00 (heure de l’est). L’appel sera présidé par M. Michael Walton, Chef de la …
TTM Technologies, Inc. Board of Directors Approves New $100 million Share Repurchase Program
GlobeNewswire
·
May 9, 2025
SANTA ANA, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI) today announced that its Board of Directors authorized a new share repurchase program allowing the Company to repurchase its outstanding common stock with an aggregate …
REMINDER: Rogers Sugar Inc.: Conference Call – 2nd Quarter 2025 Results
GlobeNewswire
·
May 9, 2025
MONTREAL, May 09, 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (RSI) will be holding a conference call to discuss their 2025 second quarter results on Tuesday, May 13, 2025, at 8:00 a.m. (Eastern Time). The conference call will be chaired by Mr. Michael …
Garuda Therapeutics Announces Name Change to Stratus Therapeutics to Reflect Mission of Pioneering Full Hematopoietic System Renewal
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Garuda Therapeutics (“Garuda”), a biotechnology company developing off-the-shelf hematopoietic stem cell (HSC) therapies, today announced that it has changed its name to Stratus Therapeutics, Inc. (“ …
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025
GlobeNewswire
·
May 9, 2025
DURHAM, N.C., May 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the …
PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights
GlobeNewswire
·
May 9, 2025
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors Interim analysis from Phase 2 PYNNACLE trial expected mid-2025; PMV plans to …
Sharc Energy Featured in Ottawa’s LeBreton Flats Redevelopment District Energy Project
GlobeNewswire
·
May 9, 2025
VANCOUVER, British Columbia, May 09, 2025 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) ("SHARC Energy" or the “Company”) is pleased to announce that two SHARC 880 Wastewater Energy Transfer (“WET”) systems …
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
GlobeNewswire
·
May 9, 2025
- This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson’s disease - RMAT designation includes the benefits of the Fast Track and Breakthrough Therapy …
NextNav Inc. Reports First Quarter 2025 Results and Operational Highlights
GlobeNewswire
·
May 9, 2025
FCC releases Notice of Inquiry (NOI) with bipartisan 4-0 vote NextNav Announces Appointment of Rear Admirals H. Wyman Howard and Lorin Selby to its Board of Directors RESTON, Va., May 09, 2025 (GLOBE NEWSWIRE) -- NextNav Inc. (NASDAQ: NN) a leader in next …
illumin Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
First Quarter Revenue of $29.1 Million up 17% YoY Exchange Service Revenue up 148% YoY (All monetary figures are expressed in Canadian dollars unless otherwise stated) TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM and OTCQB: …
N2OFF via Solterra Expands European Footprint with Entry into Fourth Project – a Battery Storage Venture in Poland
GlobeNewswire
·
May 9, 2025
N2OFF to take part in financing a 35MW/140MWh planned Battery Energy Storage System project in Poland Neve Yarak, Israel, May 09, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in …
Best 5 Tribal Loans Direct Lender Guaranteed Approval For Bad Credit with No Credit Check - Payday Ventures
GlobeNewswire
·
May 9, 2025
HOUSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Payday Ventures, a leading provider of online payday loans, owns multiple providers offering tribal loans direct lender guaranteed approval with no credit check, helping Americans with urgent financial needs get …
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
GlobeNewswire
·
May 9, 2025
PURCHASE, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, reported preclinical data this week at the Association for Research in Vision …
PyroGenesis Schedules First Quarter 2025 Financial Results and Business Update Conference Call
GlobeNewswire
·
May 9, 2025
MONTREAL, May 09, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes …
Spectral Medical Announces First Quarter and Provides Corporate Update
GlobeNewswire
·
May 9, 2025
Tigris Trial Enrollment completed Topline results expected to be released in August 2025 Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Spectral Medical …
UPCX Dubai 2049 KOL TOUR Review: Reliving the Desert, Real Connections
GlobeNewswire
·
May 9, 2025
Singapore, May 09, 2025 (GLOBE NEWSWIRE) -- On May 2, 2025, beneath the golden dunes of Dubai, a distinctive Web3 gathering quietly unfolded. Following the success of the inaugural “Proof of Connect” event in Bangkok, AllSpark Research once again joined …
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
GlobeNewswire
·
May 9, 2025
Results support potential benefit of efruxifermin (EFX) to elicit fibrosis improvement in patients with compensated cirrhosis (F4 fibrosis) due to MASH 96-week data from SYMMETRY trial presented at EASL Congress 2025 SOUTH SAN FRANCISCO, Calif., May 09, …
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
GlobeNewswire
·
May 9, 2025
~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related serious adverse events ~ ~ Held Type B FDA meetings in …
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
GlobeNewswire
·
May 9, 2025
ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS …
Kymera Therapeutics Expands Industry Leading Immunology Pipeline with New First-in-Class, Oral IRF5 Degrader Program with Potential to Address Multiple Immuno-Inflammatory Diseases
GlobeNewswire
·
May 9, 2025
IRF5 program strengthens Kymera’s oral immunology pipeline with a complementary mechanism to expand into rheumatic and other autoimmune diseases with a potential best-in-class oral drug IRF5, a historically undrugged transcription factor and master …